Daniel Cherqui is an expert in Surgery at Hôpital Paul-Brousse (France). As of October 2026, ScienceLeadR ranks Daniel Cherqui in the top 1% of experts worldwide for Liver Transplantation, Tissue Transplantation and Liver Neoplasms. Daniel Cherqui has authored 710 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 3 of them ongoing. SLR score: 1,912 (community average: 125). How the SLR is computed.

LeadR Profile

Daniel Cherqui Hôpital Paul-Brousse France
1 912 ScienceLeadR Reputation 1912
Network Map

Surgery

Subspecialties: Hepatology - Oncology - Transplantation

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1988 - 2026

Source: PubMed

Hôpital Paul-Brousse

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 710

Citations

Citations: 35 304 1st author: 45 Last author: 90 Unique author: 19


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.
PMID 42561547 — pilots, cytoreduction surgical procedures, drug therapy, liver, hepatectomy, neoplasm metastasis, prospective studies, chemotherapy
Cancer Treat Rev20260
Right (H145678) and Left (H123458) 6-Segmentectomies for Malignant Liver Tumors: A Retrospective Analysis of 237 Cases Using Contemporary Surgery Quality Indicators.
PMID 42522084 — neoplasms, mastectomy, segmental, liver, general surgery, cholangiocarcinoma, survival rate
Ann Surg20260
Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma?
PMID 42496491 — mortality, lymph node excision, neoplasms, liver, general surgery, cholangiocarcinoma, intrahepatic cholangiocarcinoma
World J Surg20260
ASO Author Reflections: Locally Advanced Intrahepatic Cholangiocarcinoma: Is R1 Resection by Necessity Justified?
PMID 42471488 — cholangiocarcinoma, intrahepatic cholangiocarcinoma
Ann Surg Oncol20260
ASO Visual Abstract: Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.
PMID 42406213 — liver, prognosis, cholangiocarcinoma, intrahepatic cholangiocarcinoma
Ann Surg Oncol20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 8
Phase 1/Phase 2 1
Phase 3 1

By status:

Completed 5
Active not recruiting 2
Not yet recruiting 1
Recruiting 1
Unknown 1

By type:

Interventional 7
Observational 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 2
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 11

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
NCT05971628 — liver transplantation, carcinoma, hepatocellular, liver, hepatectomy, transplantation, carcinoma
N/ANot yet recruiting2023
Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma
NCT05901194 — liver transplantation, carcinoma, hepatocellular, waiting lists, liver, therapeutics, transplantation, carcinoma
Phase 1/Phase 2Active not recruiting2024
Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases
NCT04163887 — neoplasms, colon, laparoscopy, liver, hepatectomy, liver neoplasms, neoplasm metastasis, postoperative complications, colonic neoplasms
N/ARecruiting2021

LeadR Networks

Main global connection map